MEGAN LEININGER: Open Payments
NPI 1457440398 · EASTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 13 payments from 9 companies in 2025. Trend: 2023 $901 · 2024 $1,062 · 2025 $1,355
Food & beverage: $1,355
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $416 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $233 |
| ABBVIE INC. | 2 | $213 |
| Gilead Sciences, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Ardelyx, Inc. | 1 | $109 |
| Intercept Pharmaceuticals, Inc. | 1 | $102 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: REZDIFFRA, ENTYVIO, Livdelzi, SKYRIZI, Wegovy, IBSRELA, OCALIVA, MAVYRET.
Industry payments across PA — which companies pay providers there.
